804 EXPOSURE–RESPONSE ANALYSES OF ASUNAPREVIR IN COMBINATION WITH DACLATASVIR PEGINTERFERON/ RIBAVIRIN AMONG PATIENTS WITH GENOTYPE 1 CHRONIC HCV INFECTION: DOSE SELECTION FOR PHASE 3 CLINICAL TRIALS

Phyllis Chan, E. Tafoya, Timothy Eley, Bing He, Patricia Méndez, David Gardiner, Eric Hughes, S. Schnittman, Richard BertzJournal of Hepatology 2013 · DOI

BibTeX
@article{chan2013exposureresponse,
  author = {Phyllis Chan and E. Tafoya and Timothy Eley and Bing He and Patricia Méndez and David Gardiner and Eric Hughes and S. Schnittman and Richard Bertz},
  title = {{804 EXPOSURE–RESPONSE ANALYSES OF ASUNAPREVIR IN COMBINATION WITH DACLATASVIR PEGINTERFERON/ RIBAVIRIN AMONG PATIENTS WITH GENOTYPE 1 CHRONIC HCV INFECTION: DOSE SELECTION FOR PHASE 3 CLINICAL TRIALS}},
  journal = {Journal of Hepatology},
  year = {2013},
  doi = {10.1016/s0168-8278(13)60806-5},
}

Loading related content...

Figure